OneMedNet Implements 1-for-10 Reverse Stock Split to Meet Nasdaq Listing Requirements
Event summary
- OneMedNet Corporation (Nasdaq: ONMD) will execute a 1-for-10 reverse stock split effective September 29, 2026.
- The split reduces outstanding shares from ~59.3 million to ~5.93 million, maintaining total authorized shares.
- Approved by stockholders on September 18, 2026, the move aims to comply with Nasdaq's minimum bid price requirement.
- Trading under the same symbol (ONMD) with a new CUSIP number (68270C 202) begins September 29, 2026.
The big picture
OneMedNet's reverse stock split is a strategic maneuver to avoid delisting, reflecting broader trends of distressed equities seeking compliance through share consolidation. The move underscores the pressure on small-cap healthcare data firms to maintain market access amid volatile trading conditions. With its iRWD platform and Palantir Foundry integration, OneMedNet's ability to monetize its 90M+ patient journeys will be critical in sustaining investor confidence.
What we're watching
- Market Perception
- How investors will react to the reduced share count and potential improved liquidity.
- Nasdaq Compliance
- Whether the reverse split will successfully maintain OneMedNet's listing status.
- Operational Impact
- The pace at which the company can leverage its data platform to drive revenue growth post-split.
